Ndeke, Denys
Sam, Sandra
Polchai, Nuanphan
Alshammari, Khalid
Greener, Megan R.
Marak, Tangkam R.
Joyce, Jimmy
Henman, Maisie
Deen, Suha
Green, Andrew R.
Ellis, Ian O.
Rakha, Emad A.
Martin, Stewart G.
Storr, Sarah J.
Article History
Received: 20 January 2026
Accepted: 3 May 2026
First Online: 18 May 2026
Declarations
:
: The authors declare no competing interests.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee, as well as the 1964 Helsinki declaration and its later amendments or comparable ethical standards. All samples collected from Nottingham used in this study were pseudo-anonymised; those collected prior to 2006 did not require informed patient consent under the Human Tissue Act; for samples collected after 2006, informed consent was obtained from all individual participants included in the study. Ethical approval for the breast cancer cohort was issued by the North West-Greater Manchester Central Research Ethics Committee under the title ‘Nottingham Health Science Biobank (NHSB)’ reference number 15/NM/0685. Ethical approval for the ovarian cancer cohort was obtained from the Derbyshire Ethics Committee (07/H0401/156).
: Not applicable.